Jiahui Chu
Impact in
- Cancer Research top 10%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Cancer Genomics and Diagnostics
- Hepatology top 10%
- Hepatocellular Carcinoma Treatment and Prognosis
Papers in
-
- MicroRNA in disease regulation 3
- Cancer, Hypoxia, and Metabolism 1
- Oncology 8
- Cancer Immunotherapy and Biomarkers 4
- HER2/EGFR in Cancer Research 3
- Co-authors
- Xian‐Jun Qu (6 shared papers)Zhiyu Song (5 shared papers)Ziyi Fu (11 shared papers)Yongmei Yin (12 shared papers)Yanhong Zhang (8 shared papers)Yongfei Li (8 shared papers)Xiang Huang (6 shared papers)Chunxiao Sun (5 shared papers)
- Journals
- Cellular Physiology and Biochemistry (5 papers)Biomedicine & Pharmacotherapy (4 papers)Cancer Letters (3 papers)癌症：英文版 (2 papers)Signal Transduction and Targeted Therapy (2 papers)
- Partner nations
- ChinaUnited StatesCanada
In The Last Decade
Jiahui Chu
36 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 49
- Cancer Research 117
- Hepatology 64
- Oncology 131
- Molecular Biology 271
- Surgery 109
Countries citing papers authored by Jiahui Chu
This map shows the geographic impact of Jiahui Chu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiahui Chu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiahui Chu more than expected).
Fields of papers citing papers by Jiahui Chu
This network shows the impact of papers produced by Jiahui Chu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiahui Chu. The network helps show where Jiahui Chu may publish in the future.
Co-authors
The 25 scholars most cited alongside Jiahui Chu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 37 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 185 | |
| 2 | 2017 | 119 | |
| 3 | 2014 | 92 | |
| 4 | 2018 | 73 | |
| 5 | 2014 | 56 | |
| 6 | 2017 | 42 | |
| 7 | 2018 | 40 | |
| 8 | 2018 | 39 | |
| 9 | 2018 | 34 | |
| 10 | 2020 | 33 | |
| 11 | 2015 | 32 | |
| 12 | 2017 | 31 | |
| 13 | 2021 | 30 | |
| 14 | 2024 | 30 | |
| 15 | 2022 | 28 | |
| 16 | 2019 | 27 | |
| 17 | 2017 | 22 | |
| 18 | 2024 | 22 | |
| 19 | 2018 | 18 | |
| 20 | 2014 | 17 |
About Jiahui Chu
Jiahui Chu is a scholar working on Cancer Research, Oncology, Hepatology, Molecular Biology and Surgery, having authored 37 papers that have together received 1.1k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (4 papers), Esophageal Cancer Research and Treatment (4 papers), MicroRNA in disease regulation (3 papers), HER2/EGFR in Cancer Research (3 papers), RNA modifications and cancer (3 papers), Hepatocellular Carcinoma Treatment and Prognosis (2 papers), Gastric Cancer Management and Outcomes (2 papers) and Cancer, Hypoxia, and Metabolism (1 paper). The work is most often cited by research in Cancer Research (117 citations), Hepatology (64 citations), Oncology (131 citations), Molecular Biology (271 citations) and Surgery (109 citations). Jiahui Chu has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Xian‐Jun Qu, Zhiyu Song, Ziyi Fu, Yongmei Yin, Yanhong Zhang, Yongfei Li, Xiang Huang, Chunxiao Sun, Yan Wang and Fan Yang. Their work appears in journals such as Cellular Physiology and Biochemistry, Biomedicine & Pharmacotherapy, Cancer Letters, 癌症：英文版 and Signal Transduction and Targeted Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.